These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3034387)

  • 1. Role of carbonic anhydrase in bone resorption: effect of acetazolamide on basal and parathyroid hormone-induced bone metabolism.
    Hall GE; Kenny AD
    Calcif Tissue Int; 1987 Apr; 40(4):212-8. PubMed ID: 3034387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone resorption induced by parathyroid hormone and dibutyryl cyclic AMP: role of carbonic anhydrase.
    Hall GE; Kenny AD
    J Pharmacol Exp Ther; 1986 Sep; 238(3):778-82. PubMed ID: 3018220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholera toxin on cyclic AMP accumulation and bone resorption in cultured mouse calvaria.
    Ransjö M; Lerner UH
    Biochim Biophys Acta; 1987 Oct; 930(3):378-91. PubMed ID: 2820504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
    Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
    J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forskolin sensitizes parathyroid hormone-induced cyclic AMP response, but not the bone resorptive effect, in mouse calvarial bones.
    Lerner UH; Ransjö M; Sahlberg K; Ljunggren O; Fredholm BB
    Bone Miner; 1989 Jan; 5(2):169-81. PubMed ID: 2537671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
    Lerner UH; Larsson A
    Bone; 1987; 8(3):179-89. PubMed ID: 2955802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heterocyclic sulfonamides on bone metabolism.
    Pierce WM; Blank JA; Waite LC
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):3-20. PubMed ID: 3001882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of carbonic anhydrase by parathyroid hormone and cyclic AMP in rat renal cortex in vitro.
    Beck N; Kim KS; Wolak M; Davis BB
    J Clin Invest; 1975 Jan; 55(1):149-56. PubMed ID: 233968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of carbonic anhydrase in bone resorption induced by 1,25 dihydroxyvitamin D3 in vitro.
    Hall GE; Kenny AD
    Calcif Tissue Int; 1985 Mar; 37(2):134-42. PubMed ID: 3924369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forskolin-induced bone resorption in neonatal mouse calvaria in vitro.
    Gunasekaran S; Hall GE; Kenny AD
    Proc Soc Exp Biol Med; 1986 Mar; 181(3):438-42. PubMed ID: 3003759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different roles for calcium and cyclic AMP in the action of PTH: studies in bone explants and isolated bone cells.
    Herrmann-Erlee MP; van der Meer JM; Löwik CW; van Leeuwen JP; Boonekamp PM
    Bone; 1988; 9(2):93-100. PubMed ID: 2841959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
    Lerner UH; Fredholm BB; Ransjö M
    Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+.
    Lehenkari P; Hentunen TA; Laitala-Leinonen T; Tuukkanen J; Väänänen HK
    Exp Cell Res; 1998 Jul; 242(1):128-37. PubMed ID: 9665810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylate cyclase blockers dissociate PTH-stimulated bone resorption from cAMP production.
    Reid IR; Lowe C; Cornish J; Gray DH; Skinner SJ
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E708-14. PubMed ID: 1692185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of bone resorption in vitro by serine-esterase inhibitors.
    Lerner UH; Gustafson GT
    Biochim Biophys Acta; 1988 Feb; 964(2):129-36. PubMed ID: 3342254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of carbonic anhydrase in bone resorption induced by prostaglandin E2 in vitro.
    Hall GE; Kenny AD
    Pharmacology; 1985; 30(6):339-47. PubMed ID: 3925470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone.
    Conaway HH; Grigorie D; Lerner UH
    J Bone Miner Res; 1996 Oct; 11(10):1419-29. PubMed ID: 8889841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.
    Lerner UH; Ransjö M; Ljunggren O
    Calcif Tissue Int; 1987 Jun; 40(6):323-31. PubMed ID: 2440532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactic acid production in mouse calvaria in vitro with and without parathyroid hormone stimulation: lack of acetazolamide effects.
    Nichols FC; Neuman WF
    Bone; 1987; 8(2):105-9. PubMed ID: 3593606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase activity in fetal rat bone resorbing cells: inhibition by acetazolamide infusion.
    Hott M; Marie PJ
    J Dev Physiol; 1989 Nov; 12(5):277-81. PubMed ID: 2517427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.